Dr. Geoffrey Scott Marecek, MD

Dr. Marecek practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Marecek's NPI, 1114183472, was assigned on August 5, 2008. Dr. Marecek graduated from Feinberg School of Medicine in 2007. Dr. Marecek holds California license A125781.

Dr. Marecek's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Marecek's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Marecek to 3 more group practices and clinics, 3 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marecek practices, 5 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Marecek's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Marecek is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Marecek's licenses on file in 3 states: California, Washington and Illinois.

Dmand AI lists amputation, broken or dislocated ankle/ or foot, hip replacement, joint or bone infection, joint pain, knee fracture and dislocation, leg, ankle or foot fracture and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Marecek treats.

CMS data shows 157 Medicare services from Dr. Marecek across 3 procedure codes in 2024, for 148 Medicare patients. Medicare paid $8,757 for them.

CMS counts 148 Medicare patients who saw Dr. Marecek in 2024. The largest group is 75 to 84, with 50 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marecek's median patient age at 61, with 56% women.

In 2024, Dr. Marecek wrote 30 Medicare Part D claims for 15 patients. 97% of them were for generic drugs. They cover 3 drugs, with $587 in total drug cost. In 2022, CMS named 79 claims across 3 drugs.

Dr. Marecek accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of removal of tissue by Dr. Marecek, more than 62% of the clinicians it reports for that procedure.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Marecek, published from 2013 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Bone Nails, Femur and Fluoroscopy. Dr. Marecek has published most often in J Am Acad Orthop Surg. Dr. Marecek's most frequent co-authors are Milton Thomas Michael Little, BS, MD, John A. Scolaro, MD and Mitchell A. Bernstein, MD.

Dmand AI links Dr. Marecek to 1 clinical trial. Conditions studied include Fractures, Open and Tibial Fractures.

CMS Open Payments shows 825 general payments to Dr. Marecek from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. Zimmer Biomet Holdings, Inc. paid the most, $270,562.

Dr. Marecek graduated from Feinberg School of Medicine in 2007. Dr. Marecek is a member of AAOS, AO Trauma North America and OTA.

Dr. Marecek is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.